• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

拓扑异构酶1与聚(ADP-核糖)聚合酶1的关联及其他:从DNA拓扑结构到断裂修复

Top1-PARP1 association and beyond: from DNA topology to break repair.

作者信息

Chowdhuri Srijita Paul, Das Benu Brata

机构信息

Laboratory of Molecular Biology, School of Biological Sciences, Indian Association for the Cultivation of Science, 2A & B, Raja S. C. Mullick Road, Jadavpur, Kolkata 700032, India.

出版信息

NAR Cancer. 2021 Feb 1;3(1):zcab003. doi: 10.1093/narcan/zcab003. eCollection 2021 Mar.

DOI:10.1093/narcan/zcab003
PMID:33981998
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8095074/
Abstract

Selective trapping of human topoisomerase 1 (Top1) on the DNA (Top1 cleavage complexes; Top1cc) by specific Top1-poisons triggers DNA breaks and cell death. Poly(ADP-ribose) polymerase 1 (PARP1) is an early nick sensor for trapped Top1cc. New mechanistic insights have been developed in recent years to rationalize the importance of PARP1 beyond the repair of Top1-induced DNA breaks. This review summarizes the progress in the molecular mechanisms of trapped Top1cc-induced DNA damage, PARP1 activation at DNA damage sites, PAR-dependent regulation of Top1 nuclear dynamics, and PARP1-associated molecular network for Top1cc repair. Finally, we have discussed the rationale behind the synergy between the combination of Top1 poison and PARP inhibitors in cancer chemotherapies, which is independent of the 'PARP trapping' phenomenon.

摘要

特定的拓扑异构酶1(Top1)毒物将人类拓扑异构酶1(Top1)选择性捕获在DNA上(Top1切割复合物;Top1cc)会引发DNA断裂和细胞死亡。聚(ADP - 核糖)聚合酶1(PARP1)是捕获的Top1cc的早期切口传感器。近年来已形成了新的机制见解,以阐明PARP1除修复Top1诱导的DNA断裂之外的重要性。本综述总结了捕获的Top1cc诱导DNA损伤的分子机制、DNA损伤位点处PARP1的激活、PAR对Top1核动力学的依赖性调节以及用于Top1cc修复的PARP1相关分子网络方面的进展。最后,我们讨论了Top1毒物与PARP抑制剂联合用于癌症化疗时协同作用背后的原理,这种协同作用与“PARP捕获”现象无关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a73/8210250/849e4cfcb01b/zcab003fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a73/8210250/cf2a969b2532/zcab003fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a73/8210250/849e4cfcb01b/zcab003fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a73/8210250/cf2a969b2532/zcab003fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a73/8210250/849e4cfcb01b/zcab003fig2.jpg

相似文献

1
Top1-PARP1 association and beyond: from DNA topology to break repair.拓扑异构酶1与聚(ADP-核糖)聚合酶1的关联及其他:从DNA拓扑结构到断裂修复
NAR Cancer. 2021 Feb 1;3(1):zcab003. doi: 10.1093/narcan/zcab003. eCollection 2021 Mar.
2
PARP1-TDP1 coupling for the repair of topoisomerase I-induced DNA damage.PARP1-TDP1 偶联修复拓扑异构酶 I 诱导的 DNA 损伤。
Nucleic Acids Res. 2014 Apr;42(7):4435-49. doi: 10.1093/nar/gku088. Epub 2014 Feb 3.
3
Poly(ADP-ribose) polymers regulate DNA topoisomerase I (Top1) nuclear dynamics and camptothecin sensitivity in living cells.聚(ADP - 核糖)聚合物调节活细胞中DNA拓扑异构酶I(Top1)的核动力学和喜树碱敏感性。
Nucleic Acids Res. 2016 Sep 30;44(17):8363-75. doi: 10.1093/nar/gkw665. Epub 2016 Jul 27.
4
Transcriptomic Analysis of CRISPR/Cas9-Mediated PARP1-Knockout Cells under the Influence of Topotecan and TDP1 Inhibitor.CRISPR/Cas9 介导的 PARP1 敲除细胞在拓扑替康和 TDP1 抑制剂影响下的转录组分析。
Int J Mol Sci. 2023 Mar 7;24(6):5148. doi: 10.3390/ijms24065148.
5
Design, synthesis and development of a dual inhibitor of Topoisomerase 1 and poly (ADP-ribose) polymerase 1 for efficient killing of cancer cells.设计、合成并开发一种拓扑异构酶 1 和聚(ADP-核糖)聚合酶 1 的双重抑制剂,以有效杀死癌细胞。
Eur J Med Chem. 2023 Oct 5;258:115598. doi: 10.1016/j.ejmech.2023.115598. Epub 2023 Jun 28.
6
PARP1-dependent DNA-protein crosslink repair.PARP1 依赖性 DNA-蛋白质交联修复。
Nat Commun. 2024 Aug 5;15(1):6641. doi: 10.1038/s41467-024-50912-x.
7
Clinical PARP inhibitors do not abrogate PARP1 exchange at DNA damage sites in vivo.临床 PARP 抑制剂不能在体内 DNA 损伤部位消除 PARP1 的交换。
Nucleic Acids Res. 2020 Sep 25;48(17):9694-9709. doi: 10.1093/nar/gkaa718.
8
XRCC1 counteracts poly(ADP ribose)polymerase (PARP) poisons, olaparib and talazoparib, and a clinical alkylating agent, temozolomide, by promoting the removal of trapped PARP1 from broken DNA.XRCC1 可拮抗聚(ADP 核糖)聚合酶(PARP)抑制剂奥拉帕利和他拉唑帕利,以及临床烷化剂替莫唑胺,促进 PARP1 从断裂的 DNA 上脱离。
Genes Cells. 2022 May;27(5):331-344. doi: 10.1111/gtc.12929. Epub 2022 Mar 1.
9
Entrapment of DNA topoisomerase-DNA complexes by nucleotide/nucleoside analogs.核苷酸/核苷类似物对DNA拓扑异构酶-DNA复合物的捕获。
Cancer Drug Resist. 2019;2(4):994-1001. doi: 10.20517/cdr.2019.95. Epub 2019 Dec 19.
10
Mechanistic insight into the role of Poly(ADP-ribosyl)ation in DNA topology modulation and response to DNA damage.聚(ADP-核糖)化在 DNA 拓扑结构调节和 DNA 损伤反应中的作用的机制见解。
Mutagenesis. 2020 Feb 13;35(1):107-118. doi: 10.1093/mutage/gez045.

引用本文的文献

1
Pathogenic variants in MAEA disrupt DNA replication fork stability and are associated with developmental abnormalities in humans.MAEA中的致病变异会破坏DNA复制叉的稳定性,并与人类发育异常相关。
Sci Adv. 2025 Aug 29;11(35):eadv0381. doi: 10.1126/sciadv.adv0381.
2
ADP-ribosylation of NuMA promotes DNA single-strand break repair and transcription.NuMA的ADP核糖基化促进DNA单链断裂修复和转录。
Cell Rep. 2025 Jun 24;44(6):115737. doi: 10.1016/j.celrep.2025.115737. Epub 2025 May 20.
3
Circadian rhythm disruption by PARP inhibitors correlates with treatment toxicity in patients with ovarian cancer and is a predictor of side effects.

本文引用的文献

1
Poly(ADP-ribose) polymerase inhibition: past, present and future.聚(ADP-核糖)聚合酶抑制:过去、现在和未来。
Nat Rev Drug Discov. 2020 Oct;19(10):711-736. doi: 10.1038/s41573-020-0076-6. Epub 2020 Sep 3.
2
The Nucleolus and PARP1 in Cancer Biology.癌症生物学中的核仁与聚(ADP-核糖)聚合酶1
Cancers (Basel). 2020 Jul 6;12(7):1813. doi: 10.3390/cancers12071813.
3
Endogenous DNA 3' Blocks Are Vulnerabilities for BRCA1 and BRCA2 Deficiency and Are Reversed by the APE2 Nuclease.内源性 DNA 3' 阻断物是 BRCA1 和 BRCA2 缺陷的脆弱性因素,可被 APE2 核酸酶逆转。
聚(ADP - 核糖)聚合酶(PARP)抑制剂引起的昼夜节律紊乱与卵巢癌患者的治疗毒性相关,并且是副作用的一个预测指标。
EBioMedicine. 2025 May 16;117:105764. doi: 10.1016/j.ebiom.2025.105764.
4
Preclinical evaluation of a novel antibody-drug conjugate OBI-992 for Cancer therapy.新型抗体药物偶联物OBI-992用于癌症治疗的临床前评估。
Sci Rep. 2025 Mar 13;15(1):8735. doi: 10.1038/s41598-025-92697-z.
5
Mechanisms underlining R-loop biology and implications for human disease.R环生物学的潜在机制及其对人类疾病的影响。
Front Cell Dev Biol. 2025 Feb 21;13:1537731. doi: 10.3389/fcell.2025.1537731. eCollection 2025.
6
PARP1-dependent DNA-protein crosslink repair.PARP1 依赖性 DNA-蛋白质交联修复。
Nat Commun. 2024 Aug 5;15(1):6641. doi: 10.1038/s41467-024-50912-x.
7
TDP1 phosphorylation by CDK1 in mitosis promotes MUS81-dependent repair of trapped Top1-DNA covalent complexes.有丝分裂中 CDK1 对 TDP1 的磷酸化促进了 MUS81 依赖性修复被捕获的 Top1-DNA 共价复合物。
EMBO J. 2024 Sep;43(17):3710-3732. doi: 10.1038/s44318-024-00169-3. Epub 2024 Jul 16.
8
A platform technology for ultra-long acting intratumoral therapy.一种用于超长作用时间肿瘤内治疗的平台技术。
Sci Rep. 2024 Jun 18;14(1):14000. doi: 10.1038/s41598-024-64261-8.
9
The proofreading exonuclease of leading-strand DNA polymerase epsilon prevents replication fork collapse at broken template strands.先导链 DNA 聚合酶 epsilon 的校对外切酶可防止断裂模板链处的复制叉崩溃。
Nucleic Acids Res. 2023 Dec 11;51(22):12288-12302. doi: 10.1093/nar/gkad999.
10
Fluorescence-resonance-energy-transfer-based assay to estimate modulation of TDP1 activity through arginine methylation.基于荧光共振能量转移的检测方法,用于评估精氨酸甲基化对TDP1活性的调节作用。
STAR Protoc. 2023 Apr 13;4(2):102218. doi: 10.1016/j.xpro.2023.102218.
Mol Cell. 2020 Jun 18;78(6):1152-1165.e8. doi: 10.1016/j.molcel.2020.05.021. Epub 2020 Jun 8.
4
SCAN1-TDP1 trapping on mitochondrial DNA promotes mitochondrial dysfunction and mitophagy.SCAN1-TDP1 在线粒体 DNA 上的捕获促进线粒体功能障碍和线粒体自噬。
Sci Adv. 2019 Nov 6;5(11):eaax9778. doi: 10.1126/sciadv.aax9778. eCollection 2019 Nov.
5
Dual Processing of R-Loops and Topoisomerase I Induces Transcription-Dependent DNA Double-Strand Breaks.R 环和拓扑异构酶 I 的双重处理诱导转录依赖性 DNA 双链断裂。
Cell Rep. 2019 Sep 17;28(12):3167-3181.e6. doi: 10.1016/j.celrep.2019.08.041.
6
The nucleolus: a central response hub for the stressors that drive cancer progression.核仁:驱动癌症进展的应激因素的中央反应枢纽。
Cell Mol Life Sci. 2019 Nov;76(22):4511-4524. doi: 10.1007/s00018-019-03231-0. Epub 2019 Jul 23.
7
PARP1 regulates DNA damage-induced nucleolar-nucleoplasmic shuttling of WRN and XRCC1 in a toxicant and protein-specific manner.PARP1 以毒物和蛋白特异性方式调控 DNA 损伤诱导的 WRN 和 XRCC1 核仁-核质穿梭。
Sci Rep. 2019 Jul 11;9(1):10075. doi: 10.1038/s41598-019-46358-7.
8
Perspectives on PARPs in S Phase.PARPs 在 S 期的作用。
Trends Genet. 2019 Jun;35(6):412-422. doi: 10.1016/j.tig.2019.03.008. Epub 2019 Apr 26.
9
UCHL3 Regulates Topoisomerase-Induced Chromosomal Break Repair by Controlling TDP1 Proteostasis.UCHL3 通过控制 TDP1 蛋白稳态调节拓扑异构酶诱导的染色体断裂修复。
Cell Rep. 2018 Jun 12;23(11):3352-3365. doi: 10.1016/j.celrep.2018.05.033.
10
PRMT5-mediated arginine methylation of TDP1 for the repair of topoisomerase I covalent complexes.PRMT5 介导的 TDP1 精氨酸甲基化修复拓扑异构酶 I 共价复合物。
Nucleic Acids Res. 2018 Jun 20;46(11):5601-5617. doi: 10.1093/nar/gky291.